Natalie Boytsov, PhD

home / authors / natalie-boytsov-phd

Articles

Defining the Teriparatide Patient: Osteoporosis Sequence of Care and Healthcare Resources

Natalie Boytsov, PhD;Maria Yu, MA;Tomoko Sugihara, MS;Ralph Swindle, PhD

February 26th 2015

This study provides real-world evidence of a teriparatide (TPTD) patientâ€™s characteristics, sequence of care, and healthcare resource utilization, and compares TPTD patients with non-TPTD patients.

Daily Dose and Costs of Therapy With Topical Testosterone Agents

Anna Kaltenboeck, MA;Natalie Boytsov, PhD;Eleanor Hayes-Larson, MPH;Alexandra M. San Roman, BA;Jasmina Ivanova, MS;Howard G. Birnbaum, PhD;Shonda Foster, MS, PharmD;Julio Vazquez, MS, PharmD;S

December 16th 2014

We assessed time to maintenance dose attainment in commercially insured men initiating topical testosterone agents and compared daily maintenance doses and costs of this therapy.

Published: October 23rd 2024 | Updated: October 24th 2024

What to Know About E Coli Outbreak Linked to McDonald’s Quarter Pounders